“Evidence for the Conversion of Docetaxel into 7-Epidocetaxel in Patients Receiving Conventional Taxotere® Based Chemotherapy”, J. Anal. Oncol., vol. 3, no. 2, pp.  73–78, Apr. 2014, doi: 10.6000/1927-7229.2014.03.02.1.